期刊文献+

Antineoplastic Effect of Calcium Channel Blocker-Verapamil and 5-Fluorouracil Intraperitoneal Chemotherapy on Hepatocarcinoma-Bearing Rats

维拉帕米联合5-氟脲嘧啶腹腔内化疗对荷肝癌大鼠的抗肿瘤作用(英文)
下载PDF
导出
摘要 Objective To study the antineoplastic effect of the calcium channel blocker verapamil and 5-fluorouracil intraperitoneal chemotherapy onhepatocarcinoma-bearing rats, and examine the action between calcium channel blockers and cytotoxic drugs.Methods We adopted the method of subcapsular implantation of carcinoma tissues of walker-256 in the left liver lobe as a model of livercarcinoma-bearing rats. All experimental animals were divided into four groups. On the sixth day post implantation, in group A (controlgroup) 6 ml of saline was injected intraperitoneally once a day for 3 days. In group B (single chemotherapy group) 6 ml of 5-Fu 75 mg/kg was injected intraperitoneally once a day for 3 days. In group C (combination of treatment group) both 5-Fu (75 mg/kg) and verapamil(25 mg/kg) were administered simultaneously as in A and B. In group D (simple verapamil group) only 6 ml of verapamil (25 mg/kg)was administered as above.Results Compared with groups A, B and D, The volume of cancer and the contents of liver cancer DNA and protein were significantlyreduced. The rates of inhibiting cancer (89.9% in group C and 35.4% in group B) were significantly increased in group C. Group C hadsignificantly long survival time compared to groups A, B and D ( P < 0.05) . By light microscopy, a number of focal necroses were foundin cancer tissue in group C.Conclusion Calcium channel blockers can enhance the antineoplastic effect of 5-Fu intraperitoneal chemotherapy to liver cancer ; Theuse of verapamil can not increase the toxicity of 5-Fu.
出处 《The Chinese-German Journal of Clinical Oncology》 CAS 2002年第2期84-87,共4页 中德临床肿瘤学杂志(英文版)
关键词 calcium channel blockers VERAPAMIL 5-FLUOROURACIL HEPATOCARCINOMA intraperitoneal chemotherapy 钙通道阻滞剂 5-氟尿嘧啶 维拉帕米 肝细胞癌 荷瘤大鼠 腹腔内化疗 抗肿瘤作用
  • 相关文献

参考文献8

  • 1Kazuo S, Ishizuka J,Cooper CW. et al. Inhibitory effect ofcalcium channel blockers on growth of pancreatic cancer cells. Pancreas, 1994, 9 (2):193-202.
  • 2Shi HA, He YC, Zou YK, et al. An experimental study on 5-Fluorouracil controlledrelease implant made of silastic elastomer. Bases & Clinics in General Surgery, 1994,1(1): 9-11.
  • 3Tamargo RJ. Interstitial chemotherapy of the 9L gliosarcoma: controlled releasepolymeras for drug delivery in the brain. Cancer Res, 1993, 53 (2): 329-332.
  • 4Milder JW. Conference on hyperthermia in cancer treatment. Cancer Res, 1979,39 (6):223l-2340.
  • 5Shiraki N, Hamada A,Ohmura T, et al. Increase in doxorubicin cytotoxicity byinhibition of p-glycoprotein activity with lomerizine. Biol Pharm Bull, 2001, 24(5):555-557.
  • 6Hamilton G, Theyer G, Baumgartner G, et al. Calcium antagonists as modulators ofmultidrug resistant tumor cells. Wien Med Wochenschr, 1993, 143C(19-20): 526-532.
  • 7Yang JL, Friedlander ML.Effect of nifedipine in metastatic colon cancer with DNAmismatch repair gene defect. Lancet, 2001,357(9270):1767-1768.
  • 8Iishi H, Tatsuta M, Baba M, et al. Suppression by verapamil of bombesin-enhancedperitoneal metastasis of intestinal adenocarcinomas induced by azoxymethane in Wistarrats. Chemotherapy, 2001,47(1): 70-76.

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部